Neogen Corp. (NEOG)
7.41
+0.15
(+2.07%)
USD |
NASDAQ |
Jan 06, 16:00
7.49
+0.08
(+1.08%)
After-Hours: 20:00
Neogen Research and Development Expense (Quarterly): 5.125M for Aug. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ResMed, Inc. | 87.32M |
| Myriad Genetics, Inc. | 28.20M |
| Amgen, Inc. | 1.90B |
| Tandem Diabetes Care, Inc. | 47.88M |
| Outlook Therapeutics, Inc. | 7.135M |